The role of platelets in immune-mediated inflammatory diseases

Abstract

Immune-mediated inflammatory diseases (IMIDs) are characterized by excessive and uncontrolled inflammation and thrombosis, both of which are responsible for organ damage, morbidity and death. Platelets have long been known for their role in primary haemostasis, but they are now also considered to be components of the immune system and to have a central role in the pathogenesis of IMIDs. In patients with IMIDs, platelets are activated by disease-specific factors, and their activation often reflects disease activity. Here we summarize the evidence showing that activated platelets have an active role in the pathogenesis and the progression of IMIDs. Activated platelets produce soluble factors and directly interact with immune cells, thereby promoting an inflammatory phenotype. Furthermore, platelets participate in tissue injury and promote abnormal tissue healing, leading to fibrosis. Targeting platelet activation and targeting the interaction of platelets with the immune system are novel and promising therapeutic strategies in IMIDs.

Self‐Assembly of Platelet Lysates Proteins into Microparticles by Unnatural Disulfide Bonds for Bottom‐Up Tissue Engineering

“…[28] In the specific case of PL proteins, they hold immunomodulatory factors that can actively inhibit immune responses, thereby reducing the risk of immunogenicity. [29] Furthermore, with the current donor screening and testing strategies used in licensed blood centers, there is low risk of contamination with human-bloodborne pathogens, making allogeneic pooled platelets a valuable option. [30] It is therefore hypothesized that such PL-derived materials could be used to produce a class of bioactive microparti-cles for a wide range of applications, including as supports for cell expansion and bioproduction, as well as moldable scaffolds for tissue engineering and disease models.…”

Long COVID is primarily a Spike protein Induced Thrombotic Vasculitis

“…Thrombi are known to develop from inflammation, in part due to platelet hyperactivation [63]. COVID-19 is a highly inflammatory disease, with potential to cause cytokine storms [64].…”

Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

“…They are the most prevalent blood component after red blood cells (RBC). Platelets are mainly responsible for sealing areas of damage to the vessel wall through aggregation (Scherlinger et al, 2023). Steady‐state platelets characterize by a discoidal shape; however, upon vascular injury, they interact with the endothelium by changing their discoidal shape to spherical and subsequently forming filopodia for adhesion.…”